In this prospective cohort study, we examined the residual gastric contents of 255 fasted patients undergoing gastrointestinal endoscopy. The volume and pH of residual gastric contents collected by suction under direct visualisation during gastroscopy were accurately quantified. All patients completed the minimum two-hour fast for clear fluids and 97.2% of patients completed the minimum six-hour fast for solids. High-risk residual gastric content, defined as volume >25 ml and pH <2.5, was present in 12.2% (95% CI 8.7% to 16.7%) of patients. We used multiple logistic regression analysis to identify demographic and clinical factors associated with high-risk residual gastric content. The odds of having high-risk residual gastric content were reduced with increase in age (adjusted odds ratio 0.77, 95% CI 0.61 to 0.96, P=0.0230), and use of a proton pump inhibitor or histamine type 2 receptor antagonist (adjusted odds ratio 0.24, 95% CI 0.10 to 0.55, P=0.0013), and were increased in male patients (adjusted odds ratio 2.36, 95% CI 1.06 to 5.28, P=0.0348). Notably, residual gastric content was classified as high-risk in 20.4% of patients who did not take a proton pump inhibitor or histamine type 2 receptor antagonist versus only 5.6% of those who did. Our findings suggest that, despite currently recommended fasting, males presenting for endoscopy are more likely to have high-risk gastric content than females, and that the incidence appears to be reduced with increasing age, and by the use of proton pump inhibitors or histamine type 2 receptor antagonists, we were unable to confirm or exclude an effect of body mass index, peptic pathology, diabetes or other clinical or demographic factors in our study population.
Gastrointestinal endoscopy is the most common procedure requiring general anaesthesia or intravenous sedation in Australia and abroad. The number of these procedures performed each year and the complexity of the patient population are increasing. Non-anaesthetists may provide intravenous sedation and most cases are performed without airway protection 1, 2 . The use of anaesthesia to facilitate colonoscopy has been identified as a risk factor for complications, with aspiration pneumonia being the most common serious complication 3 . Although rare, aspiration occurs in 0.16% to 0.18% of endoscopy procedures compared to 0.1% of all other procedures, and is associated with significant morbidity and mortality [4] [5] [6] .
Patients are considered to be at increased risk of chemical pneumonitis (Mendelson' s syndrome) if their residual gastric content has a volume >25 ml and a pH <2.5, or if solid matter is present [7] [8] [9] . Current guidelines for anaesthesia and intravenous sedation recommend patients fast preoperatively from solids for six hours and clear fluids for two hours [10] [11] [12] . In a healthy adult, this should allow for complete gastric emptying and minimise the risk of aspiration-related complications 13 . It is not known whether current fasting guidelines are appropriate for all patients, as some subgroups such as the elderly, obese, diabetics, and patients with peptic pathology (including gastric bypass or reduction surgery) have generally been excluded from prospective trials of fasting regimens 11, [14] [15] [16] [17] [18] . These subgroups could be expected to make up a substantial proportion of the population undergoing gastrointestinal endoscopy. A Cochrane Collaboration systematic review and the latest European Society of Anaesthetists' fasting guidelines have both noted the need for more research into these areas 11, 15 . This prospective cohort study aimed to assess the prevalence and associated factors of high-risk residual gastric content, defined as having volume >25 ml and pH <2.5, in fasted patients undergoing gastrointestinal endoscopy.
Methods
The study was approved by the Human Research Ethics Committee (EC00141:2011/019) of our institution and written informed consent was obtained from all participants. All patients over 16 years of age presenting for elective gastroscopy with or without colonoscopy were eligible. Those with known gastric outlet obstruction or frank gastric bleeding were excluded.
The primary outcome was the presence of high-risk residual gastric content, defined as having volume >25ml and pH <2.5. We hypothesised that high-risk residual gastric content was associated with age, obesity, peptic pathologies and diabetes. The following demographic and clinical factors were recorded: age, height, weight, sex, American Society of Anesthesiologists classification, fasting duration for clear fluids and solids, history of gastro-oesophageal reflux disease (GORD) or diabetes mellitus (including diet-controlled, type 1 and type 2). Routine premedication was not administered. Ingestion of medication known to affect gastric emptying, such as tricyclic antidepressants, opioids, pro-kinetics, proton pump inhibitors (PPI), histamine type 2 receptor antagonists (H 2 RA) and bowel preparations within 24 hours was also recorded. Peptic pathologies were diagnosed by the specialist gastroenterologist during the endoscopy procedure, and included peptic inflammation, ulceration, hiatus hernia, postoperative hiatus hernia repair and carcinoma. To ensure consistency between gastroenterologists, we defined the residual gastric content as all fluid collected from the pharynx to the pylorus. Immediately after induction of general anaesthesia, residual gastric content was aspirated via the endoscope under direct vision. Samples were stored at -20°C. The volume and presence of any solid material in the sample was recorded. The pH was measured using a combination pH electrode with microbulb and a bench top pH meter (Hanna Instruments, Woonsocket, RI, USA). For samples less than 100 µl in volume, the pH could not be recorded.
Statistical analysis
Analysis was conducted with R software (version 3.1.0, R Foundation for Statistical Computing, Vienna, Austria). Where data were missing, the number of available observations was reported. Continuous variables were reported as mean ± SD or median (IQR), and compared using Student's t-test or Mann-Whitney U test. Categorical variables were reported as frequency (percentage), and compared using chi-squared test or Fisher's exact test.
Baseline demographic and clinical factors were screened for association with high-risk residual gastric content using univariate logistic regression. Variables with univariate P <0.25 were included in the initial multiple logistic regression model. Stepwise backward elimination, in which variables with the largest non-significant P-values (>0.05) were eliminated one at a time, was applied to identify those significantly associated with high-risk residual gastric content. Confounding effect, defined as a clinically significant change (>10%) to the regression coefficient of any other factor in the model, was examined and confirmed to be absent in every step of the multivariate model building process. Co-linearity and effect modification were confirmed to be absent in the final multiple logistic regression model. The final model was confirmed to satisfy all regression assumptions (Online Appendix 1).
Results
Two hundred and sixty-three patients completed the study. No pregnant patients were enrolled. The volume of residual gastric content could not be recorded in eight patients due to sample mishandling. As such, the analysis included 255 patients for whom the risk profile of residual gastric content could be determined. Table 1 shows the demographic and clinical characteristics of the study cohort. All patients completed the minimum two-hour fast for clear fluids and 97.2% of patients (248/255) completed the minimum six-hour fast for solids.
High-risk residual gastric content was present in 12.2% of patients (31/255, 95% CI 8.7 to 16.7) (Figure 1) . The mean volume of residual gastric content was 33.5 ± 6.4 ml in highrisk patients and 8.4 ± 10.5 ml in low-risk patients (P <0.0001). The median pH of residual gastric content was 1.4 (1.1 to 1.5) in high-risk patients and 3.6 (1.7 to 5.9) in low-risk patients (P <0.0001). There were no differences in the volume or pH of residual gastric content between patients who completed the minimum six-hour fast for solids and patients who did not (mean volume 11.3 ml versus 14.0 ml, P=0.79; median pH 2.7 versus 2.0, P=0.78). Notably, residual gastric content was classified as high-risk in 20.4% of patients who did not take a PPI or H 2 RA (23/113, 95% CI 14.0 to 28.7) and only 5.6% of patients who did (8/142, 95% CI 2.9 to 10.7) (P=0.0007).
In our cohort, three factors associated with the risk profile of residual gastric content were identified (Table 2) . Increase in age was associated with a 23% reduction in the odds of having high-risk residual gastric content per ten years (adjusted odds ratio 0.77, 95% CI 0.61 to 0.96, P=0.023). Use of a PPI or H 2 RA was associated with a 76% reduction in the odds of having high-risk residual gastric content (adjusted odds ratio 0.24, 95% CI 0.10 to 0.55, P=0.0013). Male sex was associated with a 136% increase in the odds of having highrisk residual gastric content (adjusted odds ratio 2.36, 95% CI 1.06 to 5.28, P=0.0348).
Discussion
In this cohort of 255 patients undergoing gastrointestinal endoscopy with a fasting compliance rate of 100% for clear fluids and 97.2% for solids, fasting did not guarantee an empty stomach: high-risk residual gastric content was found in approximately one in eight patients (12.2%, 95% CI 8.7 to 16.7). In patients who did not take a PPI or H 2 RA, the prevalence of high-risk residual gastric content was approximately one in five. We identified three factors associated with the risk profile of residual gastric content: age and use of a PPI or H 2 RA were associated with reduced risk while male sex was associated with increased risk.
We defined residual gastric content as all liquid aspirated from the pharynx to the pylorus. Although not strictly 'gastric' content, all liquid in these regions can be inhaled . Imaging techniques such as ultrasound, magnetic resonance imaging and scintiscanning have been used in other studies for accurate measurement of gastric volume, but would not allow pH measurement [20] [21] [22] [23] . Although the aetiology of pulmonary aspiration and subsequent chemical pneumonitis (Mendelson's syndrome) is multifactorial, the availability of a substrate to be aspirated is a prerequisite and an intrinsic risk factor. The risk is necessarily reduced by having minimal residual gastric content. Our definition of high-risk residual gastric contents is conservative and is based on an animal experiment where acid was applied directly into the bronchus of monkeys 9 . We acknowledge the limitations inherent in applying information gathered from animal models to clinical studies. However, there is a paucity of clinical studies to guide the risk classification of residual gastric content. More recent work, also in monkeys, suggests that aspiration of 0.4 to 0.6 ml/kg produced mild to moderate clinical and radiological changes of aspiration while 0.8 ml/kg produced severe pneumonitis 24 . Nevertheless, any aspiration is undesirable and pulmonary aspiration of the entire available gastric contents is unlikely, so adopting a more conservative definition of high-risk residual gastric content would allow for a larger margin of safety.
The associated risk reduction observed between age and residual gastric content is consistent with the findings of others. This indicates that, based on residual gastric content alone, younger patients are at higher risk of chemical pneumonitis should pulmonary aspiration occur 25 . This is contrary to the reduction in gastric emptying rate with age demonstrated by scintiscanning techniques, but could be due to the general reduction in cellular function with age 23, 25 . We observed that the odds of having high-risk residual gastric content were approximately doubled in males. This has not been previously found. Female sex is typically associated with increased risk of gastro-oesophageal reflux and postoperative emesis due the effects of oestrogen. One study in elective endoscopy procedures found no sex differences in the prevalence of airway complications or respiratory symptoms consistent with pulmonary aspiration 4 . However, in a prospective study of patients undergoing complicated endoscopy procedures, males were more likely to require airway intervention 2 . This suggests that males may indeed be at a greater risk of pulmonary aspiration during endoscopy. Of course, high-risk residual gastric content is not the only factor affecting the likelihood of pulmonary aspiration. Nevertheless, based on residual gastric content alone, it can be hypothesised that males may be more likely to develop chemical pneumonitis should pulmonary aspiration occur. Well-designed large observational studies would be needed to explore this possibility.
As expected, use of a PPI or H 2 RA was associated with a significant reduction in residual gastric volume and acidity and the odds of having high-risk residual gastric content. Only 5.6% of patients who took a PPI or H 2 RA had high-risk residual gastric content versus 20.4% of those who did not take these agents. Currently, PPIs or H 2 RAs are only recommended as premedication for patients at increased risk of pulmonary aspiration and not for routine use 12, 26 . However, the prevalence of high-risk residual gastric content among patients not taking a PPI or H 2 RA suggests that current recommendations may need to be reviewed.
Diagnosis of a hiatus hernia or peptic inflammation was not observed to have significant associations with the risk profile of residual gastric contents in univariate or multivariate analyses. This is consistent with the pathophysiology of these conditions being predominantly related to mechanical compromise of the anti-reflux barrier formed by the gastro-oesophageal junction or disruption of peptic mucosal protection mechanisms by infective or chemical agents, respectively, rather than increased gastric volume and acidity. Factors that contribute to the development of GORD, such as poor oesophageal motility, dysfunction of the lower oesophageal sphincter and delayed gastric emptying, can be expected to increase gastric volume and acidity. However, on the contrary, the opposite relationship was observed in univariate analysis: residual gastric content was classified as high-risk in 7.5% (10/133, 95% CI 4.1 to 13.3) of patients with GORD versus 18.4% (21/114, 95% CI 12.0 to 27.0) of those without. This result was attributable to confounding effects of increased use of a PPI or H 2 RA among patients with GORD. We did not record the presence of previous bariatric surgery as it was not common in this population at the time of data collection. Hence, we cannot comment specifically on its effects on residual gastric content. This would make as an interesting area for future study.
The potential for patients with diabetes to develop an autonomic neuropathy and subsequent gastroparesis or delay in gastric emptying is well recognised 27, 28 . The ability of this study to evaluate the association between diabetes and residual gastric content was limited due to the small number of patients with diabetes in our cohort. An observational study including a larger number of patients with diabetes would be needed to evaluate this relationship.
In this cohort of 255 fasted patients undergoing gastrointestinal endoscopy, we did not observe statistically significant associations between high-risk residual gastric content and other demographic and clinical factors (body mass index, American Society of Anesthesiologists classification, fasting duration, opioids, bowel preparation, peptic pathology including hiatus hernia and peptic inflammation). While our approach was to create an epidemiological model to try to understand factors which affect high-risk residual gastric content, our study is underpowered to reliably exclude many potentially important associations. Further external validation studies of these factors' effects are necessary before generalisation of our findings outside this study population.
Conclusion
We studied the prevalence and associated factors of highrisk residual gastric content in 255 fasted patients undergoing gastrointestinal endoscopy. Residual gastric content was aspirated under direct visualisation to ensure accurate quantification of volume and acidity. High-risk residual gastric content was present in 12.2% of patients in this cohort. The odds of having high-risk residual gastric content was reduced by 23% per ten-year increase in age, reduced by 76% in patients taking a PPI or H 2 RA and increased by 136% in male patients. Notably, residual gastric content was classified as high-risk in 20.4% of patients who did not take PPIs or H 2 RAs versus only 5.6% of those who did. We were unable to confirm or exclude an effect of body mass index, peptic pathology, diabetes or other clinical or demographic factors in our study population.
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